Canada Markets close in 2 hrs 45 mins

Aion Therapeutic Inc. (AION.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.02500.0000 (0.00%)
As of 03:26PM EST. Market open.
Full screen
Previous Close0.0250
Open0.0200
Bid0.0200 x N/A
Ask0.0250 x N/A
Day's Range0.0200 - 0.0250
52 Week Range0.0150 - 0.1900
Volume155,282
Avg. Volume286,487
Market Cap3.545M
Beta (5Y Monthly)0.92
PE Ratio (TTM)N/A
EPS (TTM)-0.0670
Earnings DateSep. 30, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Aion Therapeutic Files Financials

    Toronto, Ontario--(Newsfile Corp. - November 2, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203").Management of the Company has been subject to a management cease trade order (the "MCTO") in respect of the securities of the Company issued by the applicable securities ...

  • CNW Group

    Aion Therapeutic Provides Default Status Update

    Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announces that further to its press releases of September 14, 2021 and September 28, 2021, the Company is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203").

  • CNW Group

    Aion Therapeutic Provides Notice of Default

    Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announces that it anticipates being late in filing its audited annual financial statements (the "Annual Financial Statements") and related management discussion and analysis ("MD&A") for the year ended April 30, 2021, by the prescribed deadline of August 30, 2021, and its interim financial statements (the "Interim Financial Statements") and related MD&A for the interim period ended July 31, 2021, by the prescribed deadline o